drugset / Trial / NCT00635960

Growth Hormone in Amyotrophic Lateral Sclerosis

NCT00635960

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Several drugs have been proposed for ALS. These drugs included: Topiramate, Lamotrigine, creatine, Vit. E, Pentoxifylline, etc. Although most of the trials showed a positive trend, none of them reached a statistically significant result. The only exception is the Riluzole trial, that demonstrated a small but significant reduction in mortality between treated and untreated patients. Aim of our study is to determine if the add-on of GH to treatment with Riluzole is able to reduce neuronal loss in the motor cortex of ALS patients.

Timeline

Start
2007-03
Primary completion
2009-07
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Somatropin Protein / enzyme biologic 2 iu Subcutaneous